日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group

CD74 在儿童急性髓系白血病患者中表达,是一种有希望的治疗靶点:儿童肿瘤学小组的报告

Andrew J Menssen, Chad A Hudson, Todd Alonzo, Robert Gerbing, Laura Pardo, Amanda Leonti, Jacqueline A Cook, Fan-Chi Hsu, Loren L Lott, Fangyan Dai, Collette Fearing, Keely Ghirardelli, Tiffany Hylkema, Katherine Tarlock, Keith R Loeb, Edward A Kolb, Todd Cooper, Jessica Pollard, Denise A Wells, Mic

ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial

ABCB1 SNP 可预测接受吉妥珠单抗治疗的急性髓系白血病患者的预后:儿童肿瘤组 AAML0531 试验报告

Roya Rafiee, Lata Chauhan, Todd A Alonzo, Yi-Cheng Wang, Ahlam Elmasry, Michael R Loken, Jessica Pollard, Richard Aplenc, Susana Raimondi, Betsy A Hirsch, Irwin D Bernstein, Alan S Gamis, Soheil Meshinchi, Jatinder K Lamba

Beyond ritual bronzes: identifying multiple sources of highly radiogenic lead across Chinese history

超越礼仪青铜器:探寻中国历史上多种高放射性铅的来源

Liu, Ruiliang; Rawson, Jessica; Pollard, A Mark

A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03)

一项 CXCR4 拮抗剂 plerixafor 与高剂量阿糖胞苷和依托泊苷联合治疗复发或难治性急性白血病或骨髓增生异常综合征患儿的 1 期研究:儿科肿瘤实验治疗研究者联盟研究 (POE 10-03)

Cooper, Todd M; Sison, Edward Allan Racela; Baker, Sharyn D; Li, Lie; Ahmed, Amina; Trippett, Tanya; Gore, Lia; Macy, Margaret E; Narendran, Aru; August, Keith; Absalon, Michael J; Boklan, Jessica; Pollard, Jessica; Magoon, Daniel; Brown, Patrick A